See more : Ecora Resources PLC (ECRAF) Income Statement Analysis – Financial Results
Complete financial analysis of Digital Media Solutions, Inc. (DMS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Digital Media Solutions, Inc., a leading company in the Advertising Agencies industry within the Communication Services sector.
- Deswell Industries, Inc. (DSWL) Income Statement Analysis – Financial Results
- Hong Leong Bank Berhad (5819.KL) Income Statement Analysis – Financial Results
- Rockwool A/S (ROCK-A.CO) Income Statement Analysis – Financial Results
- Kenadyr Metals Corp. (KNDYF) Income Statement Analysis – Financial Results
- Hearts and Minds Investments Limited (HM1.AX) Income Statement Analysis – Financial Results
Digital Media Solutions, Inc. (DMS)
Industry: Advertising Agencies
Sector: Communication Services
About Digital Media Solutions, Inc.
Digital Media Solutions, Inc. operates as a digital performance marketing company that offers a software delivery platform in the United States. It operates through three segments: Brand Direct, Marketplace, and Other. The company operates as a performance marketing engine for companies across various industries, including consumer finance, e-commerce, education, insurance, home services, brand performance, automotive, gig, health and wellness, and career placements. It also provides managed services that help clients to access and control the advertising expenses; and marketing automation software as a service to clients. The company was founded in 2012 and is headquartered in Clearwater, Florida.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 391.15M | 427.94M | 333.38M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 287.82M | 300.02M | 234.58M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 103.33M | 127.92M | 98.81M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 26.42% | 29.89% | 29.64% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 91.75M | 91.06M | 61.54M | 5.43M | 489.78K | 8.75K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 91.75M | 91.06M | 61.54M | 5.43M | 489.78K | 8.75K |
| Other Expenses | 28.24M | 25.40M | 17.95M | 0.00 | 0.00 | 80.00 |
| Operating Expenses | 119.99M | 116.46M | 79.50M | 5.43M | 489.78K | 8.83K |
| Cost & Expenses | 407.81M | 416.48M | 314.07M | 5.43M | 489.78K | 8.83K |
| Interest Income | 0.00 | 0.00 | 0.00 | 4.11M | 3.09M | 0.00 |
| Interest Expense | 17.37M | 14.17M | 13.73M | 0.00 | 0.00 | 10.00 |
| Depreciation & Amortization | 29.18M | 25.40M | 22.27M | 171.86K | 3.09M | 20.00 |
| EBITDA | 9.55M | 65.07M | 32.53M | -5.43M | -489.78K | -8.81K |
| EBITDA Ratio | 3.17% | 12.19% | 11.18% | 0.00% | 0.00% | 0.00% |
| Operating Income | -16.79M | 26.74M | 15.00M | -5.43M | -489.78K | -8.83K |
| Operating Income Ratio | -4.29% | 6.25% | 4.50% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -39.82M | -1.24M | -11.08M | 4.11M | 3.09M | 10.00 |
| Income Before Tax | -56.61M | 25.50M | 1.27M | -1.32M | 2.60M | -8.82K |
| Income Before Tax Ratio | -14.47% | 5.96% | 0.38% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -4.11M | 19.31M | 3.47M | -4.11M | -3.09M | 0.00 |
| Net Income | -52.50M | 6.19M | -2.20M | 2.79M | 2.60M | -8.82K |
| Net Income Ratio | -13.42% | 1.45% | -0.66% | 0.00% | 0.00% | 0.00% |
| EPS | -20.57 | 2.60 | -1.02 | 1.68 | 1.56 | 0.00 |
| EPS Diluted | -20.57 | 2.60 | -1.02 | 1.68 | 1.56 | 0.00 |
| Weighted Avg Shares Out | 2.55M | 2.35M | 2.16M | 1.67M | 1.67M | 37.50M |
| Weighted Avg Shares Out (Dil) | 2.55M | 2.38M | 2.16M | 1.67M | 1.67M | 37.50M |
DMS : Signature d'un contrat de collaboration de recherche entre l'INSERM et DMS Biotech sur le traitement du Syndrome de Détresse Respiratoire Aiguë (SDRA)
DMS : DMS Biotech participe à l'effort collectif contre le coronavirus
DMS : Mise à disposition du rapport financier semestriel 2020
DMS : Progression des résultats semestriels 2020
DMS : DMS Biotech se développe à Hong Kong avec son partenaire WKK International Limited
Scott C. Taylor Appointed to J2 Global Board of Directors
Digital Media Solutions, Inc. Announces Second Quarter Fiscal 2020 Financial Results
Source: https://incomestatements.info
Category: Stock Reports